Cost-effectiveness analysis of sintilimab combined with first-line chemotherapy in the treatment of locally advanced or metastatic non-squamous non-small cell lung cancer

WU Jing, SHEN Lixia, CAO Enhui, ZHANG Zhe, WANG Chunyan

Chinese Journal of Hospital Pharmacy ›› 2025, Vol. 45 ›› Issue (6) : 668-673.

PDF(1115 KB)
PDF(1115 KB)
Chinese Journal of Hospital Pharmacy ›› 2025, Vol. 45 ›› Issue (6) : 668-673. DOI: 10.13286/j.1001-5213.2025.06.10
Drug and Clinical Practice

Cost-effectiveness analysis of sintilimab combined with first-line chemotherapy in the treatment of locally advanced or metastatic non-squamous non-small cell lung cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 45(6): 668-673 https://doi.org/10.13286/j.1001-5213.2025.06.10

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1115 KB)

Accesses

Citation

Detail

Sections
Recommended

/